Pharmacovigilance

What is an adverse drug reaction?

An adverse reaction is a noxious and unintended effect resulting from the use of a medicinal product:

  • in accordance with the indications contained in the marketing authorization, or
  • not in accordance with the indications contained in the marketing (including overdose, misuse, abuse, medication errors), or
  • associated with occupational exposure.

What does Pharmacovigilance mean?

Pharmacovigilance has been defined by the World Health Organization as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

What should I do if I suppose I experienced an adverse drug reaction?

You should advice with your attending physician (providing all the available details about the event and your medical history) before taking any action.

Furthermore, in order to collect information on any suspect adverse drug reaction and perform Pharmacovigilance activities, Menarini Group Companies are available to be contacted through the dedicated form.

If you think you experienced a suspect adverse drug reaction with a drug marketed by Lusofarmaco, please report it by clicking here.

More information about Pharmacovigilance in European Union are available here.

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.

Pharmacovigilance

The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2021 Istituto Lusofarmaco D'Italia S.p.A.